Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection
Status:
Completed
Trial end date:
2019-03-15
Target enrollment:
Participant gender:
Summary
This is a pilot study of intervention in a group of patients with tropical spastic
paraparesis/ myelopathy to evaluate virologic and clinical response of raltegravir plus
zidovudine in this group of patients.